FOGAR, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 10.960
AS - Asia 3.218
EU - Europa 2.403
SA - Sud America 494
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 15
Totale 17.222
Nazione #
US - Stati Uniti d'America 10.885
SG - Singapore 1.278
CN - Cina 944
HK - Hong Kong 631
BR - Brasile 440
PL - Polonia 398
FI - Finlandia 376
DE - Germania 341
IT - Italia 281
SE - Svezia 253
UA - Ucraina 166
FR - Francia 135
RU - Federazione Russa 134
VN - Vietnam 109
GB - Regno Unito 105
NL - Olanda 105
IN - India 42
KR - Corea 33
CA - Canada 32
TR - Turchia 23
AT - Austria 21
BD - Bangladesh 21
IE - Irlanda 21
AR - Argentina 18
EU - Europa 18
CI - Costa d'Avorio 16
IQ - Iraq 15
JP - Giappone 15
MX - Messico 15
TW - Taiwan 13
ZA - Sudafrica 13
ES - Italia 10
VE - Venezuela 10
IR - Iran 9
MA - Marocco 8
SI - Slovenia 8
EC - Ecuador 7
ID - Indonesia 7
IL - Israele 7
RO - Romania 7
AU - Australia 6
AZ - Azerbaigian 6
CO - Colombia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
BE - Belgio 5
LT - Lituania 5
MN - Mongolia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
DZ - Algeria 4
EG - Egitto 4
KE - Kenya 4
KZ - Kazakistan 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
PK - Pakistan 4
PT - Portogallo 4
SN - Senegal 4
TN - Tunisia 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
AF - Afghanistan, Repubblica islamica di 3
BF - Burkina Faso 3
BG - Bulgaria 3
BY - Bielorussia 3
CL - Cile 3
CM - Camerun 3
CZ - Repubblica Ceca 3
DJ - Gibuti 3
GF - Guiana Francese 3
JO - Giordania 3
KG - Kirghizistan 3
MG - Madagascar 3
ML - Mali 3
PE - Perù 3
PF - Polinesia Francese 3
PH - Filippine 3
PY - Paraguay 3
AM - Armenia 2
BW - Botswana 2
BZ - Belize 2
CD - Congo 2
CV - Capo Verde 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DM - Dominica 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GM - Gambi 2
JM - Giamaica 2
LU - Lussemburgo 2
LY - Libia 2
MD - Moldavia 2
MU - Mauritius 2
MW - Malawi 2
NI - Nicaragua 2
PS - Palestinian Territory 2
Totale 17.167
Città #
Fairfield 1.086
Chandler 1.084
Woodbridge 1.057
Ann Arbor 959
Houston 793
Jacksonville 763
Ashburn 706
Singapore 698
Hong Kong 628
Wilmington 538
Cambridge 433
Bytom 390
Seattle 372
Boardman 319
Princeton 260
Santa Clara 260
Des Moines 207
Beijing 202
Medford 198
Nanjing 159
Helsinki 148
Dong Ket 109
Roxbury 106
San Diego 92
Munich 69
Guangzhou 63
Nanchang 52
Padova 50
New York 45
Shenyang 45
Hebei 39
Tianjin 35
Los Angeles 33
Changsha 30
Jiaxing 30
São Paulo 30
London 26
Jinan 24
Norwalk 24
Zhengzhou 22
Milan 20
Gangdong-gu 19
Dublin 17
Shanghai 17
Abidjan 16
Redwood City 16
Nuremberg 14
Rome 14
San Francisco 14
Falkenstein 13
Detroit 12
Washington 12
Amsterdam 11
Borås 11
Curitiba 11
Dallas 11
Rio de Janeiro 10
Bologna 9
Boston 9
Indiana 9
Kharkiv 9
Kunming 9
Lanzhou 9
Pune 9
Taizhou 9
Turku 9
Vienna 9
Ankara 8
Belo Horizonte 8
Brasília 8
Haikou 8
Johannesburg 8
Montreal 8
Ningbo 8
Rockville 8
Taipei 8
Turin 8
Warsaw 8
Chicago 7
Hangzhou 7
Ogden 7
Atlanta 6
Baku 6
Brooklyn 6
Cagliari 6
Falls Church 6
Frankfurt am Main 6
Hefei 6
Kilburn 6
Lappeenranta 6
Porto Alegre 6
Presidente Prudente 6
Salvador 6
Santo André 6
Tashkent 6
Tel Aviv 6
Tokyo 6
Toronto 6
Campinas 5
Chengdu 5
Totale 12.733
Nome #
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 195
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 194
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 194
Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. 160
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 155
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications 152
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 152
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 146
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 141
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 140
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? 131
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 131
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 131
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 130
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 129
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 128
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. 128
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 128
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 126
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 126
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 125
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 125
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 125
Does serum CAR-3 play a role in pancreatic cancer diagnosis? 123
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 123
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 122
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 120
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 120
Effect of CagA status on the sensitivity of enzyme immunoassay in diagnosis Helicobacter pylori-infected children 117
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 117
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 116
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 115
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 115
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 114
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 114
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 113
Clinical utility of TPS, TPA and CA19-9 measurement in pancreatic cancer 113
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 113
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 110
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 110
Biological variability of lymphocyte subsets of human adults’ blood 110
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases. 109
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 107
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 105
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 103
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 101
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 101
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 100
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 99
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 99
Carcinogenetic potential of the WSR cagA region. 99
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 97
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 96
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 95
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer. 95
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 95
Urinary phospholipase A2 excretion in chronic pancreatic diseases 95
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 94
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases. 94
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 94
Urinary kallikrein excretion in chronic pancreatic diseases. 94
NT-S100A8 effects on cell signalling. 93
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 93
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 93
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 91
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 91
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 91
Modulazione termica dell'espressione della subunità  catalitica della tossina difterica e delle sue varianti CRM176 e CRM197 nella terapia genica del carcinoma del pancreas 91
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 90
A new indirect chemiluminescent immunoassay to measure anti-transglutaminase antibodies: more than a promise 90
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 90
Beta-cell function in pancreatic adenocarcinoma. 89
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 89
Expression profile of pancreatic cancer cell conditioned myoblast: a 5000 muscle genes microarray analysis 88
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 87
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 87
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 86
Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment? 85
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 85
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 84
Gastropanel: a useful screening test in paediatric populations 84
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. 84
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 84
Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art. 84
Mucopolysaccharidosis type VII diagnosed from a peripheral blood smear 84
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 83
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 82
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 82
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 81
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 81
Pancreatic cancer gene therapy with diphteria toxin A (DTA) and its variants CRM176 and CRM197. 81
Predisposizione al cancro del pancreas: ruolo dei polimorfismi dei geni XRCC1, XRCC3 e CYP1A1 80
CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein? 80
[Biochemical markers of gastric functioning]. 80
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 78
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 78
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 78
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 78
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 77
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 77
Totale 10.658
Categoria #
all - tutte 60.578
article - articoli 27.532
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.549 76 142 71 120 85 109 21 151 210 170 197 197
2021/20221.871 27 368 146 82 60 161 50 143 89 31 185 529
2022/20232.282 438 260 26 267 387 363 8 122 275 26 81 29
2023/20241.088 42 136 111 75 68 176 71 97 27 56 101 128
2024/20254.716 22 234 259 207 652 100 186 291 465 176 877 1.247
2025/2026104 104 0 0 0 0 0 0 0 0 0 0 0
Totale 17.291